Observational, Real World Study Of Inflectra In Patients With Inflammatory Bowel Disease
Public ClinicalTrials.gov record NCT03801928. Field values are reproduced from the official study page; the official ClinicalTrials.gov record remains the source of truth for eligibility, enrollment, and contact information.
Data is sourced from official ClinicalTrials.gov public API records. Always review the official ClinicalTrials.gov record for the latest information.
Official title
OBSERVATIONAL, REAL WORLD STUDY OF INFLECTRA IN PATIENTS WITH INFLAMMATORY BOWEL DISEASE (IBD) IN THE UNITED STATES AND CANADA
Brief summary
Reproduced verbatim from the official ClinicalTrials.gov record. Not medical advice.
This is a prospective, observational, multicenter study conducted in adult patients with ulcerative colitis (UC) or Crohn's disease (CD). The study plans to recruit 300 subjects in the United States and Canada in which the participating physician has decided to treat with INFLECTRA. The study will evaluate treatment patterns, adherence, disease activity, remission status, relapse status, treatment satisfaction, and healthcare resource utilization. Patient outcomes will be assessed at four time points (quarterly) for approximately 52 weeks after the decision to initiate treatment with INFLECTRA.
Study identification
- NCT ID
- NCT03801928
- Recruitment status
- Completed
- Study type
- Observational
- Phase
- Not listed
- Enrollment
- 118 participants
Conditions and interventions
Eligibility (public fields only)
- Age range
- 18 Years and older
- Sex
- All
- Healthy volunteers
- Healthy volunteers not accepted
This page does not interpret eligibility. Detailed inclusion and exclusion criteria are on the official ClinicalTrials.gov record.
Study timeline
- Start date
- Feb 22, 2018
- Primary completion
- Feb 6, 2020
- Completion
- Feb 6, 2020
- Last update posted
- Mar 1, 2021
2018 – 2020
United States locations
- U.S. sites
- 11
- U.S. states
- 10
- U.S. cities
- 11
| Facility | City | State | ZIP | Site status |
|---|---|---|---|---|
| San Diego Clinical Trials | San Diego | California | 92120 | — |
| Medical Research Center Of Connecticut, LLC | Hamden | Connecticut | 06518 | — |
| Suncoast Research Group, LLC | Miami | Florida | 33135 | — |
| Illinois Gastroenterology Group | Gurnee | Illinois | 60031 | — |
| Indiana University Health Division of Gastroenterology/Hepatology | Indianapolis | Indiana | 46202 | — |
| Gastro Center of Maryland | Columbia | Maryland | 21045 | — |
| Infusion Associates N.E. | Grand Rapids | Michigan | 49525 | — |
| Trinity Health Center Medical Arts | Minot | North Dakota | 58701 | — |
| Dayton Gastroenterology, Inc. | Beavercreek | Ohio | 45440 | — |
| Paramount Medical Research & consulting, LLC | Middleburg Heights | Ohio | 44130 | — |
| The Vancouver Clinic Research | Vancouver | Washington | 98664 | — |
Site contact phone numbers, emails, and investigator names are intentionally not displayed here. Open the official ClinicalTrials.gov record for site contact information.
Non-U.S. locations
This page focuses on the U.S. directory. The official record also lists 4 non-U.S. sites.
About this trial record page
- What this page shows
- Public field values for ClinicalTrials.gov record NCT03801928, including study identification, conditions, interventions, eligibility (age, sex, healthy volunteer), timeline, and U.S. site list.
- What this page does not do
- No medical advice, eligibility judgments, treatment recommendations, study quality scoring, or AI-generated medical summaries. No site contact phone numbers, emails, or investigator names.
- Where the data comes from
- Sourced from the official ClinicalTrials.gov public API. The official record is the source of truth.
- Last refresh
- Last update posted Mar 1, 2021 · Synced Sep 11, 2026
Related: full search, browse by condition, browse by drug or therapy, browse by sponsor, browse by U.S. city.
Open the official record
The complete protocol, eligibility criteria, and contact information for NCT03801928 live on ClinicalTrials.gov.